Fewer residents with dementia are being prescribed antipsychotic medications, according to new figures heralded by the government and the nation’s largest nursing home association.
Biggest losers
By
Ashley Carman
Oct 01, 2013
Providers reveal strategies for reducing unneccessary antipsychotics use for residents with dementia, and meeting industry-wide medication reduction goals
Providers can cheer widespread quality improvement, but infection control poses a challenge: AHCA report
By
Tim Mullaney
Oct 03, 2013
More long-term care facilities are earning top marks in national quality ratings, but providers may need increased focus on infection control, according to the American Health Care Association’s...
Pain management difficult for stoic residents, those with dementia, study finds
By
Tim Mullaney
Sep 18, 2013
Effective pain management in long-term care is hampered by residents’ attitudes and caregivers’ misinterpretation of behaviors, according to newly published research in the journal Nursing...
AMDA joins campaign to reduce unnecessary tests
Sep 04, 2013
The American Medical Directors Association has joined with ABIM Foundation’s Choosing Wisely® campaign to promote discussions between healthcare providers and patients for what medical tests or...
CMS and AHCA: Providers zeroing in on antipsychotic reduction target
By
Tim Mullaney
Aug 28, 2013
Nursing homes have made strides toward reducing antipsychotic medication use among residents with dementia, according to new figures from the Centers for Medicare & Medicaid Services and the American Health...
Common antipsychotic fails as effective delirium treatment, study finds
By
Ashley Carman
Aug 22, 2013
Haloperidol, a common antipsychotic, is no more effective than a placebo in treating delirium in critically ill patients, according to a new study.
AlixaRx continues to expand; parent gives capital infusion
By
Elizabeth Newman
Aug 01, 2013
A pharmacy company on track to serve more than 400 healthcare facilities has received a $100 million investment from Fillmore Capital Partners, which owns Golden Living.